North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, and Abbott recently signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott's Alinity ci and Alinity h series diagnostic instruments, as well as professional services and informatics solutions known as AlinIQ.
The contract was the subject of a detailed and competitive procurement process conducted by NWLP. Imperial College Healthcare NHS Trust, Chelsea and Westminster NHS Foundation Trust and the Hillingdon Hospitals NHS Foundation Trust consolidated their pathology services into NWLP earlier this year to manage demand, standardise operations, improve value for money, and make use of new technologies.
Stephen Snewin, NWLP managing director, said: "NWLP aims to provide an innovative and sustainable pathology service which delivers outstanding quality for our patients and clinicians. After a highly competitive process involving multiple diagnostic equipment manufacturers, NWLP is extremely excited to be working with Abbott, which supports our vision of increased efficiency and transformation across six major sites in North West London using the latest technology."
The hospitals included in the partnership are Imperial College Healthcare NHS Trust, which comprises St Mary’s Hospital, Charing Cross Hospital, Hammersmith Hospital, Queen Charlotte and Chelsea Hospital, and the Western Eye Hospital; Chelsea & Westminster Hospital Foundation Trust, which comprises Chelsea & Westminster Hospital and West Middlesex University Hospital; and Hillingdon Hospitals NHS Foundation Trust, which comprises Hillingdon Hospital and Mount Vernon Hospital.